A Novel Approach to Blood Glucose Control in Diabetic Dogs
Diabetes mellitus is one of the most common endocrine diseases in dogs. Despite daily insulin injections, achieving stable blood glucose control often remains a challenge for veterinarians and pet owners alike. A recent pilot study by Ju-Hyun An et al. (2024) investigated the new SGLT2 inhibitor DWP16001 as an add-on therapy to insulin in diabetic dogs, with promising results.
Chitosan nanoparticles for the transport of APIs against diabetes mellitus
Diabetes mellitus can have serious consequences such as blindness, heart disease, strokes or amputations. In this publication, chitosan nanoparticles will be synthesized to improve the transport of APIs.
Chitosan in the therapy against diabetic ulcers
Around one third of all type-2 diabetes sufferers develop diabetic foot ulcers in the course of their disease. Due to biofilm formation and multi-resistant bacteria, inflammation occurs in 50% of those affected. This article presents a study investigating the treatment of these with chitosan-containing metallic nanoparticles coupled to toluidine blue as a photosensitizer.